Roche recently joined naysayers who argue the deal threatens competition in the burgeoning weight loss and diabetes drug ...

The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.

Donald Trump and Robert F. Kennedy Jr.’s recent vow to tackle public health issues together signals a shift in Republican priorities.

Telix Pharmaceuticals leverages a novel theranostic approach, offering a unique risk-reward model in the challenging biotech ...

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 819% — a market-crushing outperformance compared to 170% for the S&P 500.* They just ...

Typically, if it’s a planned handover, the CEO starts in six months to a year of being announced. Investors and employees ...

Breast cancer is on the rise in Virginia, as well as the costs associated with treatment. Vance defends MSG rally; Dodgers take 3-0 lead over Yankees ...

He has gotten large donations from and owns hundreds of thousands of dollars in stocks in drug and medical device companies.

As October draws to a close, it's time to take a look at the regulatory news that made headlines in the month and look ahead to ...

As companies hire more, as jobs get generated, everybody wants to have a better place to live, better lifestyle and this is a ...

BioSpace has been compiling a list of the most innovative and exciting biotechs for a decade. Here we take a look back at ...

Hong Kong Pharma Digital Technology Holdings filed for a 1.5 million-share initial public offering. The company said Tuesday it was expecting its IPO to price between $4 and $6 per share, adding it ...